<code id='31A93B6CA5'></code><style id='31A93B6CA5'></style>
    • <acronym id='31A93B6CA5'></acronym>
      <center id='31A93B6CA5'><center id='31A93B6CA5'><tfoot id='31A93B6CA5'></tfoot></center><abbr id='31A93B6CA5'><dir id='31A93B6CA5'><tfoot id='31A93B6CA5'></tfoot><noframes id='31A93B6CA5'>

    • <optgroup id='31A93B6CA5'><strike id='31A93B6CA5'><sup id='31A93B6CA5'></sup></strike><code id='31A93B6CA5'></code></optgroup>
        1. <b id='31A93B6CA5'><label id='31A93B6CA5'><select id='31A93B6CA5'><dt id='31A93B6CA5'><span id='31A93B6CA5'></span></dt></select></label></b><u id='31A93B6CA5'></u>
          <i id='31A93B6CA5'><strike id='31A93B6CA5'><tt id='31A93B6CA5'><pre id='31A93B6CA5'></pre></tt></strike></i>

          hotspot

          hotspot

          author:comprehensive    Page View:71
          Photo illustration of Fyodor Urnov surrounded by DNA strands. -- health coverage from STAT
          Christine Kao/STAT

          Researchers attending gene therapy meetings over the past couple years were liable to bump into a svelte, graying scientist explaining in emphatic, Russian-inflected English that the U.S. was wasting the grand potential of CRISPR gene editing.

          Fyodor Urnov, the scientist in question, estimates he gave the talk 30 to 40 times: to fellow researchers, pharma executives, Food and Drug Administration officials, congressional staff, journalists, patient advocates. “Anyone who would listen,” he says.

          advertisement

          The problem was one of scale. Sure, for-profit companies were developing cures for a small handful of genetic diseases, such as sickle cell disease. But there were hundreds of devastating conditions that CRISPR might be able to cure but that no entity was seriously working on.   

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          California Joshua trees severely burned in massive wildfire
          California Joshua trees severely burned in massive wildfire

          1:35AJoshuaTreeburnsduringtheYorkFire,July30,2023,intheMojaveNationalPreserve,Calif.TyO'neil/APCalif

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

          YichuanCao/SipaUSAGileadSciencessaidMondayitwillacquireCymaBayTherapeuticsfor$4.3billion,addinganewt